Indivior (LON:INDV) shares jumped today after the FDA approved its once-monthly buprenorphine injection for the treatment of opioid addiction in adult patients who have started therapy with a transmucosal buprenorphine product. The company’s once-monthly injection is the first medication-assisted treatment option of its kind, the regulatory agency touted. Before Indivior’s Sublocade was approved, all other available […]
Wall Street Beat
FDA clears AliveCor’s KardiaBand ECG for Apple Watch
AliveCor said today that the FDA cleared its KardiaBand electrocardiogram device for the Apple Watch, designed to monitor for early signs of atrial fibrillation. First introduced in March 2016, KardiaBand is the first medical device accessory to be cleared by the federal safety watchdog for the Apple Watch, Mountain View, Calif.-based AliveCor said. It’s designed to display […]
Biolase closes $12m rights offering
Biolase (NSDQ:BIOL) said today that it closed a rights offering that will bring in some $12 million for the dental laser maker. The offering, which expired at 5 pm Eastern yesterday, delivered subscriptions for some 26.3 million shares, Irvine, Calif.-based Biolase said. That’s about 5,000 more than planned, the company said. Biolase said it hoped to raise […]
Lung cancer expert: Smoking stigma still hurting patients, families and research
A number of therapies designed to treat patients with lung cancer have been approved this year, including products from Novartis (NYSE:NVS), Merck (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY). That progress is exciting for Dr. Fred Hirsch, the head of the International Association for the Study of Lung Cancer. “We do have a lot of good things to tell the public these days – […]
Elekta delays rollout for Unity MR-radiation therapy combo
Elekta (STO:EKTA B) today said it’s delaying the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needs more time to finalize and validate the linac control system. The Swedish company said the decision means it’s postponing its bid for CE Mark approval in the […]
Genesis Innovation Group launches $10m Cultivate(MD) medtech venture fund
Genesis Innovation Group said today it formed the Cultivate(MD) Capital Fund, which looks to manage $10 million to invest in early stage healthcare companies with a focus on medical device and orthopedic technologies. Holland, Mich.-based Genesis said it expects the Cultivate(MD) fund to be fully operational and seeking companies to invest in by early 2018. […]
Onduo taps Glytec’s insulin therapy software as part of virtual diabetes clinic
Glytec has inked a deal with Onduo to integrate the company’s Glucommander Outpatient insulin management software into Onduo’s virtual diabetes clinic. Onduo, a joint venture of Sanofi (NYSE:SNY) and Verily, is reportedly working to develop a platform that brings together medical devices, internal medicine ehr software and support from healthcare experts to help people manage their Type II diabetes. Get the […]
Dexcom inks continuous glucose monitoring deal with UnitedHealth
Shares in Dexcom (NSDQ:DXCM) rose 4% today after the company announced a partnership with UnitedHealth (NYSE:UNH) to assess if data from a continuous glucose monitor can help people with Type II diabetes manage their condition in a cost-effective way. UnitedHealth is slated to use CGM data, as well as diet and exercise activity, in a study of 10,000 people […]
Biocorp inks safety syringe deal with pharma player
Biocorp (PAR:ALCOR) said today that it inked a deal for its NewGuard safety syringe technology with “a leading global player specializing in pharmaceutical products” that it’s not allowed to name. The Issoire, France-based company said the deal call for it to integrate and commercialize the NewGuard technology into the pharma partner’s pre-filled heparin syringes, saying the […]
Philips deals lighting biz stake for $648m
Royal Philips (NYSE:PHG) said yesterday that it agreed to deal 17.1 million shares in Philips Lighting for €32 per share (about $37.90 apiece), for total proceeds of roughly $648 million (€547 million), cutting its holdings in its legacy business from 40.97% to 29.01%. As part of the deal the Dutch healthcare conglomerate agreed to buy […]
Stryker, Zimmer Biomet settle poaching spat
Stryker (NYSE:SYK) and Zimmer Biomet (NYSE:ZBH) agreed to bury the hatchet in a lawsuit Stryker brought accusing its orthopedics rival of poaching sales reps. Kalamazoo, Mich.-based Stryker sued Zimmer Biomet in March in the U.S. District Court for Southern Texas, alleging “concerted and deliberate unfair competition, improper use of Stryker’s confidential and trade secret information, and improper solicitations of Stryker’s customers and […]